United Therapeutics Corporation Is A Biotechnology Company Founded In 1996 And Based In Silver Springmarylandthe Company Is Dedicated To Developing Innovative Treatments For Chronic Illnessesparticularly Pulmonary Arterial Hypertensionpahand Other Rare Diseasesit Has Achieved Significant Milestonesincluding The Approval Of Several Drugs For Pahsuch As Remodulinorenitramand Tyvasoas Well As Unituxin For High Risk Neuroblastoma The Company Emphasizes Research And Developmentinvesting $412 Million Annually To Create Novel Therapies And Technologiesunited Therapeutics Is Also Exploring Advancements In Organ Bioprinting And Ex Vivo Lung Perfusion To Enhance The Availability Of Transplantable Organswith A Strong Commitment To Patient Safety And Access To Medicineunited Therapeutics Aims To Address The Needs Of Patients With Rare And Chronic Diseasesas Of 2023The Company Reported A Revenue Of $2 1 Billion And Employed Approximately 1 237 People
